Mild cognitive impairment (MCI) is a condition intermediate between physiological brain aging and dementia. Amnesic‐MCI (aMCI) subjects progress to dementia (typically to Alzheimer‐Dementia = AD) at an annual rate which is 20… Click to show full abstract
Mild cognitive impairment (MCI) is a condition intermediate between physiological brain aging and dementia. Amnesic‐MCI (aMCI) subjects progress to dementia (typically to Alzheimer‐Dementia = AD) at an annual rate which is 20 times higher than that of cognitively intact elderly. The present study aims to investigate whether EEG network Small World properties (SW) combined with Apo‐E genotyping, could reliably discriminate aMCI subjects who will convert to AD after approximately a year.
               
Click one of the above tabs to view related content.